Impact of the COVID-19 Pandemic on Global TAVR Activity : The COVID-TAVI Study
Copyright © 2024 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved..
BACKGROUND: The COVID-19 pandemic adversely affected health care systems. Patients in need of transcatheter aortic valve replacement (TAVR) are especially susceptible to treatment delays.
OBJECTIVES: This study sought to evaluate the impact of the COVID-19 pandemic on global TAVR activity.
METHODS: This international registry reported monthly TAVR case volume in participating institutions prior to and during the COVID-19 pandemic (January 2018 to December 2021). Hospital-level information on public vs private, urban vs rural, and TAVR volume was collected, as was country-level information on socioeconomic status, COVID-19 incidence, and governmental public health responses.
RESULTS: We included 130 centers from 61 countries, including 65,980 TAVR procedures. The first and second pandemic waves were associated with a significant reduction of 15% (P < 0.001) and 7% (P < 0.001) in monthly TAVR case volume, respectively, compared with the prepandemic period. The third pandemic wave was not associated with reduced TAVR activity. A greater reduction in TAVR activity was observed in Africa (-52%; P = 0.001), Central-South America (-33%; P < 0.001), and Asia (-29%; P < 0.001). Private hospitals (P = 0.005), urban areas (P = 0.011), low-volume centers (P = 0.002), countries with lower development (P < 0.001) and economic status (P < 0.001), higher COVID-19 incidence (P < 0.001), and more stringent public health restrictions (P < 0.001) experienced a greater reduction in TAVR activity.
CONCLUSIONS: TAVR procedural volume declined substantially during the first and second waves of the COVID-19 pandemic, especially in Africa, Central-South America, and Asia. National socioeconomic status, COVID-19 incidence, and public health responses were associated with treatment delays. This information should inform public health policy in case of future global health crises.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
|---|---|
| Enthalten in: |
JACC. Cardiovascular interventions - 17(2024), 3 vom: 12. Feb., Seite 374-387 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Aortic valve stenosis |
|---|
| Anmerkungen: |
Date Completed 16.02.2024 Date Revised 16.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jcin.2023.10.041 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366710400 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366710400 | ||
| 003 | DE-627 | ||
| 005 | 20240216232720.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240108s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jcin.2023.10.041 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1295.xml |
| 035 | |a (DE-627)NLM366710400 | ||
| 035 | |a (NLM)38180419 | ||
| 035 | |a (PII)S1936-8798(23)01436-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Armario, Xavier |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Impact of the COVID-19 Pandemic on Global TAVR Activity |b The COVID-TAVI Study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.02.2024 | ||
| 500 | |a Date Revised 16.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a BACKGROUND: The COVID-19 pandemic adversely affected health care systems. Patients in need of transcatheter aortic valve replacement (TAVR) are especially susceptible to treatment delays | ||
| 520 | |a OBJECTIVES: This study sought to evaluate the impact of the COVID-19 pandemic on global TAVR activity | ||
| 520 | |a METHODS: This international registry reported monthly TAVR case volume in participating institutions prior to and during the COVID-19 pandemic (January 2018 to December 2021). Hospital-level information on public vs private, urban vs rural, and TAVR volume was collected, as was country-level information on socioeconomic status, COVID-19 incidence, and governmental public health responses | ||
| 520 | |a RESULTS: We included 130 centers from 61 countries, including 65,980 TAVR procedures. The first and second pandemic waves were associated with a significant reduction of 15% (P < 0.001) and 7% (P < 0.001) in monthly TAVR case volume, respectively, compared with the prepandemic period. The third pandemic wave was not associated with reduced TAVR activity. A greater reduction in TAVR activity was observed in Africa (-52%; P = 0.001), Central-South America (-33%; P < 0.001), and Asia (-29%; P < 0.001). Private hospitals (P = 0.005), urban areas (P = 0.011), low-volume centers (P = 0.002), countries with lower development (P < 0.001) and economic status (P < 0.001), higher COVID-19 incidence (P < 0.001), and more stringent public health restrictions (P < 0.001) experienced a greater reduction in TAVR activity | ||
| 520 | |a CONCLUSIONS: TAVR procedural volume declined substantially during the first and second waves of the COVID-19 pandemic, especially in Africa, Central-South America, and Asia. National socioeconomic status, COVID-19 incidence, and public health responses were associated with treatment delays. This information should inform public health policy in case of future global health crises | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a aortic valve stenosis | |
| 650 | 4 | |a coronavirus disease 2019 | |
| 650 | 4 | |a transcatheter aortic valve replacement | |
| 650 | 4 | |a valvular heart disease | |
| 700 | 1 | |a Carron, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Simpkin, Andrew J |e verfasserin |4 aut | |
| 700 | 1 | |a Elhadi, Mohamed |e verfasserin |4 aut | |
| 700 | 1 | |a Kennedy, Ciara |e verfasserin |4 aut | |
| 700 | 1 | |a Abdel-Wahab, Mohamed |e verfasserin |4 aut | |
| 700 | 1 | |a Bleiziffer, Sabine |e verfasserin |4 aut | |
| 700 | 1 | |a Lefèvre, Thierry |e verfasserin |4 aut | |
| 700 | 1 | |a Wolf, Alexander |e verfasserin |4 aut | |
| 700 | 1 | |a Pilgrim, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Villablanca, Pedro A |e verfasserin |4 aut | |
| 700 | 1 | |a Blackman, Daniel J |e verfasserin |4 aut | |
| 700 | 1 | |a Van Mieghem, Nicolas M |e verfasserin |4 aut | |
| 700 | 1 | |a Hengstenberg, Christian |e verfasserin |4 aut | |
| 700 | 1 | |a Swaans, Martin J |e verfasserin |4 aut | |
| 700 | 1 | |a Prendergast, Bernard D |e verfasserin |4 aut | |
| 700 | 1 | |a Patterson, Tiffany |e verfasserin |4 aut | |
| 700 | 1 | |a Barbanti, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Webb, John G |e verfasserin |4 aut | |
| 700 | 1 | |a Behan, Miles |e verfasserin |4 aut | |
| 700 | 1 | |a Resar, Jon |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Mao |e verfasserin |4 aut | |
| 700 | 1 | |a Hildick-Smith, David |e verfasserin |4 aut | |
| 700 | 1 | |a Spence, Mark S |e verfasserin |4 aut | |
| 700 | 1 | |a Zweiker, David |e verfasserin |4 aut | |
| 700 | 1 | |a Bagur, Rodrigo |e verfasserin |4 aut | |
| 700 | 1 | |a Teles, Rui |e verfasserin |4 aut | |
| 700 | 1 | |a Ribichini, Flavio L |e verfasserin |4 aut | |
| 700 | 1 | |a Jagielak, Dariusz |e verfasserin |4 aut | |
| 700 | 1 | |a Park, Duk-Woo |e verfasserin |4 aut | |
| 700 | 1 | |a Kornowski, Ran |e verfasserin |4 aut | |
| 700 | 1 | |a Wykrzykowska, Joanna J |e verfasserin |4 aut | |
| 700 | 1 | |a Bunc, Matjaz |e verfasserin |4 aut | |
| 700 | 1 | |a Estévez-Loureiro, Rodrigo |e verfasserin |4 aut | |
| 700 | 1 | |a Poon, Karl |e verfasserin |4 aut | |
| 700 | 1 | |a Götberg, Matthias |e verfasserin |4 aut | |
| 700 | 1 | |a Jeger, Raban V |e verfasserin |4 aut | |
| 700 | 1 | |a Ince, Hüseyin |e verfasserin |4 aut | |
| 700 | 1 | |a Packer, Erik J S |e verfasserin |4 aut | |
| 700 | 1 | |a Angelillis, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Nombela-Franco, Luis |e verfasserin |4 aut | |
| 700 | 1 | |a Guo, Yingqiang |e verfasserin |4 aut | |
| 700 | 1 | |a Savontaus, Mikko |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Moghairi, Abdulrahman M |e verfasserin |4 aut | |
| 700 | 1 | |a Parasca, Catalina Andreea |e verfasserin |4 aut | |
| 700 | 1 | |a Kliger, Chad |e verfasserin |4 aut | |
| 700 | 1 | |a Roy, David |e verfasserin |4 aut | |
| 700 | 1 | |a Molnár, Levente |e verfasserin |4 aut | |
| 700 | 1 | |a Silva, Mariana |e verfasserin |4 aut | |
| 700 | 1 | |a White, Jonathon |e verfasserin |4 aut | |
| 700 | 1 | |a Yamamoto, Masanori |e verfasserin |4 aut | |
| 700 | 1 | |a Carrilho-Ferreira, Pedro |e verfasserin |4 aut | |
| 700 | 1 | |a Toggweiler, Stefan |e verfasserin |4 aut | |
| 700 | 1 | |a Voudris, Vassileios |e verfasserin |4 aut | |
| 700 | 1 | |a Ohno, Yohei |e verfasserin |4 aut | |
| 700 | 1 | |a Rodrigues, Inês |e verfasserin |4 aut | |
| 700 | 1 | |a Parma, Radosław |e verfasserin |4 aut | |
| 700 | 1 | |a Ojeda, Soledad |e verfasserin |4 aut | |
| 700 | 1 | |a Toutouzas, Kostas |e verfasserin |4 aut | |
| 700 | 1 | |a Regueiro, Ander |e verfasserin |4 aut | |
| 700 | 1 | |a Grygier, Marek |e verfasserin |4 aut | |
| 700 | 1 | |a AlMerri, Khaled |e verfasserin |4 aut | |
| 700 | 1 | |a Cruz-González, Ignacio |e verfasserin |4 aut | |
| 700 | 1 | |a Fridrich, Viliam |e verfasserin |4 aut | |
| 700 | 1 | |a de la Torre Hernández, José M |e verfasserin |4 aut | |
| 700 | 1 | |a Noble, Stephane |e verfasserin |4 aut | |
| 700 | 1 | |a Kala, Petr |e verfasserin |4 aut | |
| 700 | 1 | |a Asmarats, Lluis |e verfasserin |4 aut | |
| 700 | 1 | |a Kurt, Ibrahim Halil |e verfasserin |4 aut | |
| 700 | 1 | |a Bosmans, Johan |e verfasserin |4 aut | |
| 700 | 1 | |a Erglis, Martins |e verfasserin |4 aut | |
| 700 | 1 | |a Casserly, Ivan |e verfasserin |4 aut | |
| 700 | 1 | |a Iskandarani, Dounia |e verfasserin |4 aut | |
| 700 | 1 | |a Bhindi, Ravinay |e verfasserin |4 aut | |
| 700 | 1 | |a Kefer, Joelle |e verfasserin |4 aut | |
| 700 | 1 | |a Yin, Wei-Hsian |e verfasserin |4 aut | |
| 700 | 1 | |a Rosseel, Liesbeth |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Hyo-Soo |e verfasserin |4 aut | |
| 700 | 1 | |a O'Connor, Stephen |e verfasserin |4 aut | |
| 700 | 1 | |a Hellig, Farrel |e verfasserin |4 aut | |
| 700 | 1 | |a Sztejfman, Matias |e verfasserin |4 aut | |
| 700 | 1 | |a Mendiz, Oscar |e verfasserin |4 aut | |
| 700 | 1 | |a Pineda, Andres M |e verfasserin |4 aut | |
| 700 | 1 | |a Seth, Ashok |e verfasserin |4 aut | |
| 700 | 1 | |a Pllaha, Elton |e verfasserin |4 aut | |
| 700 | 1 | |a de Brito, Fabio S |c Jr |e verfasserin |4 aut | |
| 700 | 1 | |a Bajoras, Vilhelmas |e verfasserin |4 aut | |
| 700 | 1 | |a Balghith, Mohammed A |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Eid-Lidt, Guering |e verfasserin |4 aut | |
| 700 | 1 | |a Vandeloo, Bert |e verfasserin |4 aut | |
| 700 | 1 | |a Vaz, Vinicius Daher |e verfasserin |4 aut | |
| 700 | 1 | |a Alasnag, Mirvat |e verfasserin |4 aut | |
| 700 | 1 | |a Ussia, Gian Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Tay, Edgar |e verfasserin |4 aut | |
| 700 | 1 | |a Mayol, Jorge |e verfasserin |4 aut | |
| 700 | 1 | |a Gunasekaran, Sengottuvelu |e verfasserin |4 aut | |
| 700 | 1 | |a Sardella, Gennaro |e verfasserin |4 aut | |
| 700 | 1 | |a Buddhari, Wacin |e verfasserin |4 aut | |
| 700 | 1 | |a Kao, Hsien-Li |e verfasserin |4 aut | |
| 700 | 0 | |a et al |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t JACC. Cardiovascular interventions |d 2008 |g 17(2024), 3 vom: 12. Feb., Seite 374-387 |w (DE-627)NLM186220162 |x 1876-7605 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2024 |g number:3 |g day:12 |g month:02 |g pages:374-387 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jcin.2023.10.041 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 17 |j 2024 |e 3 |b 12 |c 02 |h 374-387 | ||